Similarly, inhibitors of JAK-STAT represent an encouraging therapeutic strategy to counteract the progression to more severe conditions [21,22], given the deep involvement of this transduction pathway in the onset of cytokine storms in COVID-19 [23]. This evidence concerns the gene SOAT1 and COVID-19.